Nuclear Medical Imaging Lantheus

nuclear Medical Imaging Lantheus
nuclear Medical Imaging Lantheus

Nuclear Medical Imaging Lantheus In a report released today, Richard Newitter from Truist Financial assigned a Buy rating to Lantheus (LNTH – Research Report) The Global Nuclear Medicine Market is valued at approximately USD 894 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 194% over the forecast period 2024-2032 Read the

nuclear Medical Imaging Lantheus
nuclear Medical Imaging Lantheus

Nuclear Medical Imaging Lantheus JonesTrading analyst Justin Walsh has reiterated their bullish stance on LNTH stock, giving a Buy rating today Justin Walsh has given his Buy Global Medical Imaging Reagents Market is valued at approximately USD 16 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 66% during the forecast period 2024-2032 The global radiopharmaceuticals market size is calculated at USD 674 billion in 2024 and is expected to achieve around USD 1367 billion by 2033, representing a healthy CAGR of 82% from 2024 to 2033

Comments are closed.